Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
Authors:
- Mark D. HurwitzMHMark D. Hurwitz
- Irving D. KaplanIKIrving D. Kaplan
- Jorgen L. HansenJHJorgen L. Hansen
- Savina Prokopios-DavosSPSavina Prokopios-Davos
- George P. TopulosGTGeorge P. Topulos
- Kenneth WishnowKWKenneth Wishnow
- Judith ManolaJMJudith Manola
- Bruce A. BornsteinBBBruce A. Bornstein
- Kullervo HynynenKHKullervo Hynynen
- 1 November 2005
- journal article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 21 (7) , 649-656
Abstract
Hyperthermia is used to treat several pelvic tumours. An important step in establishing a broader role for hyperthermia in treatment of prostate cancer is verification of an acceptable toxicity profile. In this report, short- and long-term toxicity profiles of a completed phase II trial of transrectal ultrasound hyperthermia combined with radiation in treatment of locally advanced prostate cancer are presented. Thirty-seven patients enrolled on a phase II study of external beam radiation +/- androgen suppression with two transrectal ultrasound hyperthermia treatments were assessed for short- and long-term toxicity. Prostatic and anterior rectal wall temperatures were monitored. Rectal wall temperatures were limited to 40 degrees C (19 patients), 41 degrees C (three patients) and 42 degrees C (15 patients). Univariate logistic regression was used to estimate the log hazard of developing NCI CTC Grade 2 toxicity based on temperature parameters. Hazard ratios, 95% confidence intervals, p-values for statistical significance of each parameter and proportion of variability explained for each of the parameters were calculated. Median follow-up was 42 months. Both short- and long-term GI toxicity were limited to grade 2 or less. Acute grade 2 proctitis was greater for patients with allowable rectal wall temperature of >40 degrees C. Eleven of 18 patients in this group had acute grade 2 proctitis vs three of 19 patients with rectal wall temperatures limited to 40 degrees C (p = 0.004). Long-term grade 2 GI and GU toxicity occurred in 5% and 19% of patients. No late grade 3 or greater toxicity occurred. Late GI and GU toxicity were not associated with the allowable rectal wall temperature. Transrectal ultrasound hyperthermia combined with radiation for treatment of advanced clinically localized prostate cancer is safe and well tolerated.Keywords
This publication has 13 references indexed in Scilit:
- Thermoradiotherapy Using Interstitial Self-Regulating Thermoseeds: An Intermediate Analysis of a Phase II TrialEuropean Urology, 2004
- Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary resultsBJU International, 2003
- Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: A preliminary reportInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermiaInternational Journal of Hyperthermia, 2003
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trialThe Lancet, 2000
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostateInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Thermal dose determination in cancer therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984